Inventor
Janice K. Albrecht
Inventor
Winter Park, FL, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes55%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
10,906,978Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD12320216,824,768'Ribavirin-pegylated interferon alfa induction HCV combination therapy'20046,472,373'Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection'20026,387,365'Combination therapy for chronic hepatitis C infection'20026,299,872'Combination therapy for chronic hepatitis c infection'20016,172,046'Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2004Patents assigned to SCHERING CORP (5)· patent assignee history
2001–2004Based in Winter Park, FL, US· patent location history
2021Patents assigned to SANOFI SA (1)· patent assignee history
2021Based in Frankfurt am Main, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHERING CORP | 5 | 2001–2004 |
| SANOFI SA | 1 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Winter Park, Florida, US | 5 | 2001–2004 |
| Frankfurt am Main, DE | 1 | 2021 |